Immunogenic and isotype-specific responses to Russian and US cold-adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice

Journal of Medical Virology

Volumn 65, Issue 1, 2001, Pages 171-177

  Michel, Detlef ^a   Hhn, Simone ^a   Haller, Tobias ^b   Jun, Dou ^a   Mertens, Thomas ^a,b  

^a Abteilung Virologie   (Germany)

^b MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Cold adapted; Donor strain; Immunogenicity; Influenza; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCING CELL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; IMMUNOGENICITY; INFLUENZA; INFLUENZA VIRUS A; LUNG; MALE; MEDIASTINUM LYMPH NODE; MOUSE; NONHUMAN; STRAIN DIFFERENCE; VACCINATION; VACCINE PRODUCTION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY-PRODUCING CELLS; COLD; HUMANS; IMMUNOGLOBULIN ISOTYPES; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H2N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LUNG; LYMPH NODES; MALE; MICE; MICE, INBRED BALB C; REASSORTANT VIRUSES; VACCINATION;

EID: 0034897815     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.2017     Document Type: Article

References (35)

1. Free recirculation of memory B cells versus antigen-dependent differentiation to antibody-forming cells
2. Functionally distinct T cells in three compartments of the respiratory tract after influenza virus infection
3. Lymphocyte recruitment to the lung
4. Long-term antibody production after lung immunisation and challenge: Role of lung and lymphoid tissue
5. Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine
6. Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2)
7. Comparative studies of A/Leningrad/134/57 wild-type and 47-times passaged cold-adapted mutant influenza viruses: Oligonucleotide mapping and RNA-RNA hybridisation studies
8. IgG2a restriction of murine antibodies elicited by viral infections
9. Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use
10. IgG isotype distribution of local and systemic immune responses induced by influenza virus infection
11. Recombinants of cold-adapted attenuated influenza A vaccines for use in children: Molecular analysis of the cold-adapted donor and recombinants
12. Evaluation of live attenuated influenza vaccines in children 6-18 months of age: Safety, immunogenicity, and efficacy
13. The immunoglobulin G subclass responses of mice to influenza virus: The effect of mouse strain, and the neutralising abilities of individual protein A purified subclass antibodies
14. The IgG subclass responses to influenza virus haemagglutinin in the mouse: Effect of route of inoculation
15. Influenza virus-specific antibody-secreting cells in the murine lung during primary influenza virus infection
16. Antibody-forming cell response to virus challenge in mice immunised with DNA encoding the influenza virus haemagglutinin
17. The B-cell response in lymphoid tissue of mice immunised with various antigenic forms of the influenza virus haemagglutinin
18. Long term maintenance of B cell immunity to influenza virus haemagglutinin in mice following DNA-based immunisation
19. Cold-adapted live attenuated influenza vaccines developed in Russia: Can they contribute to meeting the needs for influenza control in other countries?
20. Development of cold-adapted recombinant live attenuated influenza vaccines in the USA and USSR
21. Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren
22. Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus
23. Cross-protection in mice with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity
24. The regulation of pulmonary immunity
25. Adaptation and growth characteristics of influenza virus at 25°C
26. Generalised linear models
27. Infectivity and reactogenicity of reassortant cold-adapted influenza A/Korea/1/82 vaccines obtained from the USA and USSR
28. Virus-neutralising antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice
29. A simple method for estimating 50 per cent endpoints
30. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity
31. Distinctive kinetics of the antibody-forming cell response to Sendai Virus infection of mice in different anatomical compartments
32. The relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca and parental strains with similar surface antigens
33. The immunogenicity of reassortants of the cold-adapted influenza A master strain A/Ann Arbor/6/60 is determined by both the genes for cold-adaptation and the haemagglutination gene
34. High-yield reassortant influenza vaccine production virus has a mutation at an HLA-A 2.1-restricted CD8+ CTL epitope on the NS1 protein
35. Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: Importance of interferon-γ production and local IgA response